Lifevantage CSO sells 9,001 shares at $6.18

Lifevantage’s Chief Sales Officer reported market sales totaling 9,001 shares and a 2,254-share tax or exercise-price disposition over three days in September 2026.

Rhea-AI Filing Summary

Lifevantage Corp (LFVN) reported that Chief Sales Officer Kristen Cunningham executed several transactions in the company’s common stock. On September 14, 2026, she sold 8,901 shares at a weighted average price of $6.18 per share, with individual trade prices ranging from $6.15 to $6.26. She also sold 100 shares at $6.41 on September 11, 2026, and on September 10, 2026, 2,254 shares were delivered or withheld for payment of exercise price or tax liability at $6.37 per share. No Rule 10b5-1 trading plan is reported for these transactions.

Insider Trade Summary

Net Seller: 9,001 shares

Net Sell 3 txns

Insider Cunningham Kristen

Role Chief Sales Officer

Sold 9,001 shs ($56K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	8,901	$6.18	$55K
Sale	Common Stock	100	$6.41	$641.00
Exercise Price or Tax Liability	Common Stock	2,254	$6.37	$14K

Holdings After Transaction: Common Stock — 120,162 shares (Direct)

Footnotes (1)

1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.15 to $6.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold September 14, 2026: 8,901 shares Weighted average sale price September 14, 2026: $6.18 per share Shares sold September 11, 2026: 100 shares +2 more

5 metrics

Shares sold September 14, 2026 8,901 shares Common stock sale by Chief Sales Officer at weighted average price

Weighted average sale price September 14, 2026 $6.18 per share Multiple trades in a price range of $6.15 to $6.26

Shares sold September 11, 2026 100 shares Common stock sale by Chief Sales Officer

Sale price September 11, 2026 $6.41 per share Open-market or private sale of common stock

Shares delivered/withheld for exercise price or tax liability 2,254 shares Disposition on September 10, 2026 at $6.37 per share

Key Terms

weighted average price, Rule 10b5-1, tax liability

3 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Rule 10b5-1 regulatory

"No Rule 10b5-1 trading plan is reported for these transactions."

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

tax liability financial

"payment of exercise price or tax liability by delivering or withholding securities"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did LFVN’s Chief Sales Officer report in this Form 4?

Kristen Cunningham reported three transactions: market sales totaling 9,001 shares on September 14 and 11, 2026, and a 2,254-share disposition on September 10, 2026 for payment of exercise price or tax liability.

How many LFVN shares did the Chief Sales Officer sell on September 14, 2026?

On September 14, 2026, Kristen Cunningham sold 8,901 shares of Lifevantage common stock at a weighted average price of $6.18 per share, with individual trades executed between $6.15 and $6.26 per share.

What was the purpose of the 2,254-share LFVN transaction on September 10, 2026?

The September 10, 2026 transaction involved 2,254 shares of Lifevantage common stock delivered or withheld for payment of exercise price or tax liability, at a reported price of $6.37 per share.

Were the LFVN insider sales made under a Rule 10b5-1 trading plan?

No. The filing shows the Rule 10b5-1 checkbox as not selected, and no footnote states that these transactions were made under a Rule 10b5-1 or other pre-arranged trading plan.

What prices were realized in the LFVN share sales by the Chief Sales Officer?

Reported prices were a weighted average of $6.18 per share (range $6.15–$6.26) for 8,901 shares sold on September 14, 2026, and $6.41 per share for 100 shares sold on September 11, 2026.

Does the Form 4 state how many LFVN shares the insider owns after these transactions?

No. For each reported transaction, the post-transaction holdings field is left blank, so the number of Lifevantage shares held after these trades is not stated in this Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 06:56 PM Accepted by SEC EDGAR 09/14/2026 - 06:55 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cunningham Kristen

(Last) (First) (Middle)

3300 TRIUMPH BLVD, SUITE 700

(Street)

LEHI UTAH 84043

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Sales Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/10/2026		F		2,254	D	$6.37	129,163	D
Common Stock	09/11/2026		S		100	D	$6.41	129,063	D
Common Stock	09/14/2026		S		8,901	D	$6.18(1)	120,162	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.15 to $6.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Kristen Cunningham	09/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)